c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming
Abstract Background Metabolic reprogramming is a hallmark of cancer. Metabolic rate‐limiting enzymes and oncogenic c‐Myc (Myc) play critical roles in metabolic reprogramming to affect tumourigenesis. However, a systematic assessment of metabolic rate‐limiting enzymes and their relationship with Myc...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2023-01-01
|
| Col·lecció: | Clinical and Translational Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ctm2.1164 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
